GU Tumor Board®: Real World Strategies to Inform Individualized Care in Renal Cell Carcinoma

Introduction and Pre-Assessment Questions

Managing RCC in 2024 – Setting the Stage with Current Evidence

Clinical Case #1: Adjuvant treatment selection for Patients with High-Risk ccRCC who Urdergo Nephrectomy

Clinical Case #2: Selection of Frontline Therapy for Patients with Poor-Risk mccRCC

Clinical Case #3: Treatment Selection for Patients with Relapsed/Refractory mccRCC

Clinical Case #4: Treatment Selection for Patients with Non-Clear Cell (Papillary) mRCC

Virtual Tumor Board: Applying Recent Evidence Across Real-World Patient Case Scenarios